ENTITY
Sansure Biotech

Sansure Biotech (688289 CH)

29
Analysis
Health CareChina
Sansure Biotech Inc. operates as an in vitro diagnostic solution provider. The Company develops and sells upstream nucleic acid extraction kits, novel coronavirus nucleic acid detection kits, and other products. Sansure Biotech markets its products worldwide.
more
Refresh
bullishPiotech
25 Aug 2023 07:33

STAR50 Index Rebalance Preview: Potential Changes Playing Catchup

Changes will be announced after market close today. The potential adds have outperformed the potential deletes by over 10% since the end of the...

Logo
787 Views
Share
17 Aug 2023 17:39

Quiddity Leaderboard CSI 300/​​500 Dec 23: US$2.5bn One-Way Turnover; Some Changes to Expectations

The 13 CSI 300 Expected ADDs and DELs could see US$824mn index buying and US$534mn index selling. The 50 CSI 500 Expected ADDs and DELs could see...

Share
04 Jul 2023 05:40

CSI500 Index Rebalance Preview: Potential Adds Outperforming Potential Deletes

We see 50 changes a side for the CSI500 in Dec. The Industrials sector could take a lot of index spots from Materials as one-way turnover exceeds...

Logo
496 Views
Share
bullishPiotech
15 Jun 2023 06:20

STAR50 Index Rebalance Preview: One High Probability Change; One 'It Depends'

There could be 2 changes in September if a 6 month minimum listing history is used. Piotech was added to the CSI500 in June and there are multiple...

Logo
514 Views
Share
27 May 2023 12:21

STAR50 Index Rebalance: Two Changes in June (As Expected)

There are 2 changes for the STAR50 Index as a 6-month minimum listing history is used. There is little increase in excess volume on the adds while...

Logo
541 Views
Share
x